Found: 98
Select item for more details and to access through your institution.
Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment outcomes and prognosis of patients with primary and acquired BRAF‐mutated non‐small cell lung cancer: A multicenter retrospective study.
- Published in:
- Genes, Chromosomes & Cancer, 2022, v. 61, n. 9, p. 530, doi. 10.1002/gcc.23043
- By:
- Publication type:
- Article
Chinese pediatric and adolescent primary tracheobronchial tumors: a hospital-based study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
High‐throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion.
- Published in:
- Cancer Communications, 2021, v. 41, n. 2, p. 192, doi. 10.1002/cac2.12133
- By:
- Publication type:
- Article
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39139-4
- By:
- Publication type:
- Article
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 5, p. 1, doi. 10.1038/s41419-021-03754-0
- By:
- Publication type:
- Article
Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-021-03410-7
- By:
- Publication type:
- Article
Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study.
- Published in:
- Medical Science Monitor, 2018, v. 24, p. 6750, doi. 10.12659/MSM.909691
- By:
- Publication type:
- Article
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development and validation of prognostic nomogram for T<sub>1-3</sub>N<sub>0</sub>M<sub>0</sub> non-small cell lung cancer after curative resection.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11158-w
- By:
- Publication type:
- Article
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01897-y
- By:
- Publication type:
- Article
Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.657283
- By:
- Publication type:
- Article
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572853
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of anlotinib monotherapy or anlotinib plus immune checkpoint inhibitor for advanced small cell lung cancer with brain metastases.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1687, doi. 10.1007/s12094-024-03390-y
- By:
- Publication type:
- Article
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma.
- Published in:
- Current Oncology, 2022, v. 29, n. 12, p. 9452, doi. 10.3390/curroncol29120743
- By:
- Publication type:
- Article
Targeting KRAS mutant cancers: from druggable therapy to drug resistance.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01629-2
- By:
- Publication type:
- Article
Targeting KRAS mutant cancers: from druggable therapy to drug resistance.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01629-2
- By:
- Publication type:
- Article
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00264-w
- By:
- Publication type:
- Article
Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis.
- Published in:
- Open Medicine, 2023, v. 18, n. 1, p. 1, doi. 10.1515/med-2023-0653
- By:
- Publication type:
- Article
Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 6309, doi. 10.2147/CMAR.S314060
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02466-9
- By:
- Publication type:
- Article
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 20, p. 17987, doi. 10.1007/s00432-023-05490-8
- By:
- Publication type:
- Article
Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7341, doi. 10.1007/s00432-023-04615-3
- By:
- Publication type:
- Article
Apatinib plus Chemotherapy as a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1640, doi. 10.1634/theoncologist.2020-0519
- By:
- Publication type:
- Article
Proton pump inhibitors enhance macropinocytosis‐mediated extracellular vesicle endocytosis by inducing membrane v‐ATPase assembly.
- Published in:
- Journal of Extracellular Vesicles, 2024, v. 13, n. 4, p. 1, doi. 10.1002/jev2.12426
- By:
- Publication type:
- Article
Extracellular vesicles: Natural liver‐accumulating drug delivery vehicles for the treatment of liver diseases.
- Published in:
- Journal of Extracellular Vesicles, 2020, v. 10, n. 2, p. 1, doi. 10.1002/jev2.12030
- By:
- Publication type:
- Article
Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 154, doi. 10.1002/cam4.978
- By:
- Publication type:
- Article
Patients with ROS1 rearrangement-positive non-small-cell lung cancer benefit from pemetrexed-based chemotherapy.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 10, p. 2688, doi. 10.1002/cam4.809
- By:
- Publication type:
- Article
Mutation and prognostic analyses of PIK3 CA in patients with completely resected lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 10, p. 2694, doi. 10.1002/cam4.852
- By:
- Publication type:
- Article
Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3166, doi. 10.1111/1759-7714.15105
- By:
- Publication type:
- Article
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 26, p. 2715, doi. 10.1111/1759-7714.15022
- By:
- Publication type:
- Article
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 12, p. 1102, doi. 10.1111/1759-7714.14847
- By:
- Publication type:
- Article
Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 91, doi. 10.1111/1759-7714.14743
- By:
- Publication type:
- Article
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 23, p. 3420, doi. 10.1111/1759-7714.14693
- By:
- Publication type:
- Article
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3084, doi. 10.1111/1759-7714.14644
- By:
- Publication type:
- Article
Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients.
- Published in:
- World Journal of Surgical Oncology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7819-11-62
- By:
- Publication type:
- Article
Analysis of the tumor length and other prognosis factors in pT1-2 node-negative esophageal squamous cell carcinoma in a Chinese population.
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 273, doi. 10.1186/1477-7819-10-273
- By:
- Publication type:
- Article
Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 6, p. 816, doi. 10.1007/s10637-023-01400-4
- By:
- Publication type:
- Article
Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.10777
- By:
- Publication type:
- Article
Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31141-6
- By:
- Publication type:
- Article
The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia.
- Published in:
- Contrast Media & Molecular Imaging, 2022, p. 1, doi. 10.1155/2022/2256690
- By:
- Publication type:
- Article
Joint Serum Tumor Markers Serve as survival predictive model of Erlotinib in the treatment of recurrent Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2014, v. 17, n. 5, p. 391, doi. 10.3779/j.issn.1009-3419.2014.05.05
- By:
- Publication type:
- Article
Relationship Between BIM Gene Polymorphism and Therapeutic Efficacy in the Retreatment of Advanced Non-small Cell Lung Cancer with Tyrosine Kinase Inhibitor.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 12, p. 632, doi. 10.3779/j.issn.1009-3419.2013.12.03
- By:
- Publication type:
- Article